|国家科技期刊平台
首页|期刊导航|中国普通外科杂志|术中超声造影在肝脏恶性肿瘤手术中的应用价值

术中超声造影在肝脏恶性肿瘤手术中的应用价值OA北大核心CSTPCD

The application value of intraoperative contrast-enhanced ultrasound in the surgery for malignant liver tumors

中文摘要英文摘要

背景与目的:目前手术治疗仍然是肝脏恶性肿瘤主要根治性治疗措施之一.但是有时由于肿瘤微小、位置深在、多发或继发性肝癌经药物治疗后形成"消失的肝转移灶"等原因,导致手术时无法准确定位肿瘤或遗漏.本研究探讨术中超声造影(CE-IOUS)在肝脏恶性肿瘤手术中的应用价值. 方法:回顾分析复旦大学附属中山医院2022年9月-2023年2月期间收治且接受手术切除的56例肝恶性肿瘤患者,比较术前增强核磁共振成像(P-MRI),术前超声(P-US)、术中超声(IOUS)和CE-IOUS对肝脏病灶检出率、恶性肿瘤诊断准确率的差异. 结果:56例患者共85个病灶,行P-MRI检测到的75个病灶,术后病理诊断为恶性病灶64个,良性病灶11个,遗漏10个;P-US检测到的46个病灶,术后病理诊断为恶性病灶30个,良性病灶16个,遗漏39个;IOUS检测到的64个病灶,术后病理诊断为恶性病灶44个,良性病灶20个,遗漏21个;行CE-IOUS诊断为恶性的78个病灶,术后病理检查为恶性病灶66个,良性病灶12个,遗漏7个.CE-IOUS较P-US及IOUS有较高的病灶检出率,差异有统计学意义(91.8%vs.54.1%,P<0.001;91.8%vs.75.3%,P<0.001);对于肝脏占位的恶性肿瘤诊断准确率,CE-IOUS比P-US及IOUS高(86.8%vs.65.2%,P<0.001;86.8%vs.68.7%,P<0.001).对于病灶检出率、恶性肿瘤诊断准确率,CE-IOUS和P-MRI差异无统计学意义. 结论:利用Sonazoid造影剂进行CE-IOUS较P-US和IOUS具有较高的肿瘤检出率及恶性肿瘤诊断准确率,可用于发现和定位术前无法显示的微小病灶,进而在其引导下进行肿瘤切除或射频消融,提高手术疗效.

Background and Aims:Currently,Surgical resection is still the main radical approach for malignant liver tumors.However,sometimes due to reasons such as small tumor size,deep location,multiple occurrences,or secondary liver cancer forming"disappearing liver metastases"after drug treatment,it is challenging to accurately locate or detect the tumor during surgery.This study was performed to explore the application value of intraoperative contrast-enhanced ultrasound(CE-IOUS)in the surgery of malignant liver tumors. Methods:A retrospective analysis was conducted on 56 patients with malignant liver tumors who were treated and underwent surgical resection at Zhongshan Hospital,Fudan University,from September 2022 to February 2023.The detection rates of liver lesions and the diagnostic accuracy rates for malignant tumors among preoperative enhanced magnetic resonance imaging(P-MRI),preoperative ultrasound(P-US),intraoperative ultrasound(IOUS),and CE-IOUS were compared. Results:There were a total of 85 lesions in the 56 patients,among which,P-MRI detected 75 lesions,with postoperative pathology diagnosing 64 malignant lesions and 11 benign lesions,while 10 lesions were missed;P-US detected 46 lesions,with postoperative pathology diagnosing 30 malignant lesions and 16 benign lesions,while 39 lesions were missed;IOUS detected 64 lesions,with postoperative pathology diagnosing 44 malignant lesions and 20 benign lesions,while 21 lesions were missed;CE-IOUS diagnosed 78 lesions as malignant,with postoperative pathology confirming 66 malignant lesions and 12 benign lesions,while 7 lesions were missed.CE-IOUS had a significantly higher lesion detection rate compared to P-US and IOUS(91.8%vs.54.1%,P<0.001;91.8%vs.75.3%,P<0.001)and a higher diagnostic accuracy rate compared to P-US and IOUS(86.8%vs.65.2%,P<0.001;86.8%vs.68.7%,P<0.001).There was no statistically significant difference between CE-IOUS and P-MRI in terms of lesion detection rate,diagnostic accuracy for malignant tumors,and misdiagnosis rate. Conclusion:Using Sonazoid contrast agent for CE-IOUS has a higher tumor detection rate and diagnostic accuracy for malignant liver tumors compared to P-US and IOUS.It can be used to identify and locate small lesions that cannot be displayed before surgery,to guide tumor resection or radiofrequency ablation and thereby improve surgical efficacy.

杨兴广;成剑文;许阳;孙云帆;周俭;杨欣荣

复旦大学附属中山医院肝肿瘤外科,上海 200032||大理大学第一附属医院普通外科,云南大理 671013复旦大学附属中山医院肝肿瘤外科,上海 200032

临床医学

肝肿瘤超声检查,术中造影剂肝切除术

Liver NeoplasmsUltrasonography,IntraoperativeContrast MediaHepatectomy

《中国普通外科杂志》 2024 (007)

1051-1058 / 8

上海市卫生健康委员会卫生健康领军人才计划基金资助项目(2022LJ005);上海市卫生健康委员会卫生行业临床研究专项基金资助项目(201940075).

10.7659/j.issn.1005-6947.2024.07.004

评论